Company intelligence / Profile preview

Lipidor

Danderyd, Stockholm County, Swedenlipidor.se ↗
Ownership
Private
Employees
~9
Development stage
Phase 3
01

Overview

Lipidor develops novel lipid-based topical pharmaceuticals using its proprietary AKVANO technology. The company’s lead program has reached Phase III clinical trials as of March 2025. Its pipeline includes reformulated products for common dermatological conditions such as psoriasis and acne. The company partners with global pharma firms to accelerate the development and commercialization of innovative skin treatments.

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Small molecule (reformulation of proven pharmaceutical substances)Nanoparticle (lipid-based delivery)Device (sprayable topical formulations)Biologic (potential for chemical and biological APIs via partnerships)
Industry
Biotech
02

Drug pipeline

4 assets

AKP01

4

3 more assets in the full pipeline.

03

Partnerships

Cerbios‐Pharma (API development/manufacturing)Aurena Laboratories AB (manufacturing bag-on-valve aerosol sprays)

Beyond the preview

Go deeper on Lipidor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipidor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call